Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
2,536,179
-
Shares change
-
+491,809
-
Total reported value, excl. options
-
$437,086,452
-
Value change
-
+$86,720,586
-
Number of buys
-
63
-
Number of sells
-
-38
-
Price
-
$172.42
Significant Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q1 2015
117 filings reported holding IHE - ISHARES TR - U.S. PHARMA ETF as of Q1 2015.
ISHARES TR - U.S. PHARMA ETF (IHE) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,536,179 shares
.
Largest 10 shareholders include MORGAN STANLEY (378,751 shares), BANK OF MONTREAL /CAN/ (317,905 shares), BANK OF AMERICA CORP /DE/ (248,231 shares), WELLS FARGO & COMPANY/MN (153,689 shares), ARS Wealth Advisors, LLC (128,384 shares), Brookstone Capital Management (105,856 shares), LPL Financial LLC (94,962 shares), ROYAL BANK OF CANADA (91,240 shares), BROWN ADVISORY INC (86,458 shares), and Braver Wealth Management, LLC (74,114 shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.